The global mucosal atomization devices market was estimated to be worth US$ 460.4 million in 2021 and is expected to increase to US$ 837.7 million by 2029, according to a recent market study by Future Market Insights (FMI).
A new market research report by Future Market Insights on the mucosal atomization devices market includes global industry analysis 2014–2021 and opportunity assessment 2022–2029. Mucosal atomization devices market was valued at ~US$ 490.2 Mn in 2022, and is expected to increase at a robust CAGR of ~8% during the forecast period. The demand growth is majorly driven by superior efficiency and painless drug delivery nature of mucosal automization devices, according to the report.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-7101
The market is still young, and FMI’s analysis expects a considerable increase in penetration rate over the course of coming years, in line with the thriving trends, such as non-invasive treatments and needleless drug delivery systems.
Developed regional markets are expected to hold prominent market share in terms of value. The market in Asia Pacific is also expected to grow at a significant rate. North America is expected to account for leading revenue shares in the mucosal atomization devices over the foreseeable future, predominantly attributing to the technological advancements in the field of healthcare. The rate of adoption of drug delivery devices has been envisaged to remain high in Europe, which is driving the region’s mucosal atomization devices market. On the other side, the market in Asia Pacific is expected to grow at a significant growth rate as a result of the increasing frequency of new and efficient medical device launches.
Mucosal Atomization Devices Market Segmentation
The global market of mucosal atomization devices has been segmented on the basis of product type, technology, end user and regions such as North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East and Africa
By product type, nasal atomization devices are expected to hold prominent value shares of the global mucosal atomization devices market. Nasal passage is the most common route of administration, hence, nasal atomization devices are expected to show significant growth in the mucosal atomization devices market.
On the basis of technology, gas propelled atomization devices are expected to hold a large revenue share in the mucosal atomization devices market. Most of the key players operating in mucosal atomization devices market, are manufacturing gas propelled mucosal atomization devices.
On the basis of end user, hospitals hold a significant share in the mucosal atomization devices market. The number of hospitals are increasing, especially in the developed regions, which is expected to increase the demand for mucosal atomization devices, increasing the growth of the mucosal atomization devices market.
Unlock exclusive insights with our expert analysts:
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-7101
Mucosal Atomization Devices Market: Vendor Insights
The report highlights some of the prominent market players, who have established themselves as leaders in the global mucosal atomization devices market. Some of the examples of key players in the global mucosal atomization devices market are Teleflex Incorporated, DeVilbiss Healthcare LLC, Cook Medical Incorporated, and Medica Holdings, LLC, Kurve Technology. There are only few key players in the mucosal atomization devices market.
Key players are majorly focusing on the development of new and technologically advanced mucosal atomization devices. Key players are also involved in acquisitions and collaborations, which can increase the growth of the mucosal atomization devices market.
Mucosal Atomization Devices Market by Category:
By Product Type:
- Nasal Atomization Devices
- Fiber Optic Atomization Devices
- Laryngo Tracheal Atomization Devices
- Bottle Atomizers
By Technology:
- Gas Propelled Atomization Devices
- Electrical Atomization Devices
By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialized Clinics
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
